Wilson Therapeutics
Wilson Therapeutics AB is a privately-held biopharmaceutical company focused on developing novel treatments for Wilson Disease;a rare
Wilson Therapeutics has raised €36M across 1 funding round, most recently a round in Apr 2014. Based in Stockholm, Sweden; founded 2007; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€36M
€36,000,000
Funding rounds
1
Investors
0
distinct backers
Active since
2014-04
latest 2014-04
Funding by year
EUR raised per yearWilson Therapeutics — funding by year — interactive chart.
Data table
| Wilson Therapeutics — funding by year | |
|---|---|
| 2014 | €36M |
Signals
Medium confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2014-04-01 | Other | €36M | — | View deal → |
Similar companies
same sector or countryGlobal coverage: FundingData